IRIS Research and Development, LLC

Plantation, Florida 33324-2736

3 studies enrolling now · 17 studies all time

What they study most

Chronic Uncontrolled Gout, Diffuse Cutaneous Systemic Sclerosis, Gout, Granulomatosis With Polyangiitis, Lupus Erythematosus, Systemic, Myositis, Pemphigus Vulgaris, Rheumatoid Arthritis, Scleroderma, Sclerosis, Systemic, Sjogren's Syndrome, Systemic Lupus Erythematosus

Studies at this site

• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
• A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] — Recruiting now
• Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. — Recruiting now
• A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus — Running, not enrolling
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — Running, not enrolling
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome — Stopped early
• An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) — Stopped early
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome — Completed